Angioplasty Balloons Global Market Report 2024 by The Business Research Company | Johnson & Johnsona, Abbott Laboratories, Medtronic Plc, Becton Dickinson, Koninklijke Philips N.V, Boston Scientific Corporation, B. Braun SE, Terumo Corporation, Cook Medic

The angioplasty balloons market size has grown steadily in recent years. It will grow from $2.6 billion in 2023 to $2.73 billion in 2024 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to increasing clinical trials, decreasing regulatory hurdles, rising physician training programs, growing reimbursement coverage, and expanding patient awareness and education.

The angioplasty balloon market size is expected to see steady growth in the next few years. It will grow to $3.31 billion in 2028 at a compound annual growth rate (CAGR) of 5%. The growth in the forecast period can be attributed to aging population, rising prevalence of cardiovascular diseases, expanding healthcare infrastructure in emerging markets, increasing adoption of minimally invasive procedures, and growing demand for interventional cardiology. Major trends in the forecast period include personalized treatment approaches, integration of advanced imaging technologies, shift towards outpatient procedures, expansion of telemedicine for post-operative care, and emphasis on cost-effective healthcare solutions.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=15509&type=smp

Angioplasty Balloons Market Major Segments
The angioplasty balloons market covered in this report is segmented -

1) By Product Type: Normal Balloons, Scoring Balloons, Drug-Eluting Balloons, Cutting Balloons
2) By Material: Non-Compliant, Semi-Compliant
3) By Application: Coronary Angioplasty, Peripheral Angioplasty
4) By End User: Hospitals, Specialty Clinics, Catheterization Laboratories, Ambulatory Surgical Centers, Other End Users

Key Driver - Rising Steel Industry Demand Fuels Growth Of Hydraulic Ironworker Machine Market

The increasing incidence of cardiovascular diseases is expected to propel the angioplasty balloons market going forward. Cardiovascular disease refers to a group of conditions affecting the heart and blood vessels, often leading to complications such as heart attacks or strokes. Cardiovascular disease is on the rise due to sedentary lifestyles, unhealthy dietary habits, rising obesity rates, and aging populations. The angioplasty balloons are utilized in cardiovascular disease to widen narrowed or blocked blood vessels, restoring proper blood flow and reducing the risk of complications such as heart attacks or strokes. For instance, in May 2023, according to the Centers for Disease Control And Prevention, a US-based governmental organization, the percentage of coronary heart disease in adults aged 18 and over in 2020 was 4.6%, which slightly increased to 4.9% in 2021. Therefore, the increasing incidence of cardiovascular diseases drives the growth of the angioplasty balloons market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=15509&type=smp

Prominent Trend - Next-Gen Angioplasty Balloons Revolutionize Treatment With PowerTrac Technology

Major companies operating in the angioplasty balloons market are focused on developing products with PowerTrac technology to gain a competitive edge. PowerTrac technology is an innovative system utilized in medical devices, particularly in angioplasty balloons, to enhance tracking and pushability through tortuous vessels during procedures. For instance, in July 2021, Medtronic Plc, an Ireland-based medical technology company, launched a Prevail drug-coated balloon (DCB) catheter in Europe for the treatment of coronary artery disease. The Prevail DCB uses PowerTrac technology and a hydrophilic coating to provide superior deliverability and two times more pushability. This enables greater control for tortuous anatomies. It employs a fast-absorbing drug, paclitaxel, to treat de novo lesions, small vessel disease, and in-stent restenosis (ISR). Unlike drug-eluting stents (DES), DCB angioplasty doesn't necessitate a permanent implant and is preferred for situations where DES implantation is unsuitable or technically difficult.

Angioplasty Balloons Market Players
Major companies operating in the angioplasty balloons market are Johnson & Johnsona, Abbott Laboratories, Medtronic Plc, Becton Dickinson, Koninklijke Philips N.V, Boston Scientific Corporation, B. Braun SE, Terumo Corporation, Cook Medical, Biotronik SE, Merit Medical Systems Inc , Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, AngioDynamics, Cordis, SurModics, iVascular, Hexacath, Balton Sp, Cardionovum, QualiMed Innovative Medizinprodukte GmbH, Acrostak, Panmed US Inc., Translumina GmbH, Concept Medical Inc

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/angioplasty-balloons-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the angioplasty balloons market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angioplasty balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Angioplasty Balloons Market Report Structure
3. Angioplasty Balloons Market Trends And Strategies
4. Angioplasty Balloons Market - Macro Economic Scenario
5. Angioplasty Balloons Market Size And Growth
…..
27. Angioplasty Balloons Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.